- Home
- SMXT vs CTMX Comparison
SMXT vs CTMX Comparison
Compare SMXT & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMXT
- CTMX
- Stock Information
- Founded
- SMXT 2008
- CTMX 2008
- Country
- SMXT United States
- CTMX United States
- Employees
- SMXT 76
- CTMX N/A
- Industry
- SMXT
- CTMX Biotechnology: Pharmaceutical Preparations
- Sector
- SMXT
- CTMX Health Care
- Exchange
- SMXT NYSE
- CTMX Nasdaq
- Market Cap
- SMXT 54.5M
- CTMX 60.7M
- IPO Year
- SMXT 2024
- CTMX 2015
- Fundamental
- Price
- SMXT $1.16
- CTMX $2.65
- Analyst Decision
- SMXT
- CTMX Strong Buy
- Analyst Count
- SMXT 0
- CTMX 2
- Target Price
- SMXT N/A
- CTMX $5.00
- AVG Volume (30 Days)
- SMXT 105.9K
- CTMX 11.4M
- Earning Date
- SMXT 05-16-2025
- CTMX 05-12-2025
- Dividend Yield
- SMXT N/A
- CTMX N/A
- EPS Growth
- SMXT N/A
- CTMX 128.27
- EPS
- SMXT N/A
- CTMX 0.49
- Revenue
- SMXT $24,150,276.00
- CTMX $147,557,000.00
- Revenue This Year
- SMXT N/A
- CTMX N/A
- Revenue Next Year
- SMXT N/A
- CTMX N/A
- P/E Ratio
- SMXT N/A
- CTMX $5.46
- Revenue Growth
- SMXT N/A
- CTMX 23.81
- 52 Week Low
- SMXT $0.60
- CTMX $0.40
- 52 Week High
- SMXT $7.46
- CTMX $2.82
- Technical
- Relative Strength Index (RSI)
- SMXT N/A
- CTMX 70.52
- Support Level
- SMXT N/A
- CTMX $1.97
- Resistance Level
- SMXT N/A
- CTMX $2.82
- Average True Range (ATR)
- SMXT 0.00
- CTMX 0.28
- MACD
- SMXT 0.00
- CTMX 0.02
- Stochastic Oscillator
- SMXT 0.00
- CTMX 71.05
About SMXT SOLARMAX TECHNOLOGY INC
SolarMax Technology Inc is an integrated solar and renewable energy company. It operates in two segments namely the United States and China. The United States business includes the sale and installation of photovoltaic and battery backup systems. China operations consist of operating and maintaining solar farm projects and identifying and procuring solar farm projects for resale to third parties. Some of its products are LG Solar Panels, QCELL Solar Panels, Panasonic Solar Panels, and others. The company generates a majority of its revenue from the Solar energy systems.
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.